Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study.

DISCUSSION: The supplementation of 30 mg/d of MMFP in combination with 80 mg/d of ascorbic acid in advanced cancer patients with hyposideraemia led to a significant increase in sideraemia and ferritinaemia. Moreover, in some of the patients whose serum iron level did not increase, an increase in haemoglobin was observed.
PMID: 30865583 [PubMed - as supplied by publisher]

Source: Blood Transfusion - February 17, 2019 Category: Hematology Authors: Pappalardo A, Currenti W, Ponzio R, Mellini G, Nicolosi D, Longhitano L, Tibullo D, Castorina S, Palumbo G Tags: Blood Transfus Source Type: research